Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta‐analysis

BACKGROUND: Clopidogrel, prasugrel and ticagrelor, acting on platelet P2Y12 receptor, are commonly used for prevention of stent thrombosis (ST) among patients who underwent percutaneous coronary intervention (PCI). This study aimed to compare the effects of these drugs by a systematic review and net...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Cardiol
Главные авторы: Chen, Wenwen, Zhang, Chen, Zhao, Jian, Xu, Xiuxiu, Dang, Heqin, Xiao, Qiang, Li, Yuanmin, Hou, Haifeng
Формат: Artigo
Язык:Inglês
Опубликовано: Wiley Periodicals, Inc. 2021
Предметы:
Clinical Investigations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027588/
https://ncbi.nlm.nih.gov/pubmed/33704801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23536
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы